---
title: "TJPC: Subsidiary TJPC HePing has obtained the drug registration certificate for Difluprednate Eye Drops"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254752001.md"
description: "TJPC announced that its subsidiary, Tianyao Heping Pharmaceutical Co., Ltd., has received the \"Drug Registration Certificate\" for Difluprednate Eye Drops issued by the National Medical Products Administration. This drug is primarily used to treat inflammation and pain related to eye surgery. Tianyao Heping has invested approximately 53.2734 million yuan in research and development for this project. Currently, Difluprednate Eye Drops is the first generic drug in the country. The global sales are projected to be USD 33 million and USD 24 million for 2023 and 2024, respectively"
datetime: "2025-08-27T07:35:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254752001.md)
  - [en](https://longbridge.com/en/news/254752001.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254752001.md)
---

# TJPC: Subsidiary TJPC HePing has obtained the drug registration certificate for Difluprednate Eye Drops

TJPC announced that its subsidiary Tianyao Heping Pharmaceutical Co., Ltd. has received the "Drug Registration Certificate" for Difluprednate Eye Drops issued by the National Medical Products Administration. This drug is mainly used to treat inflammation and pain related to eye surgery. Tianyao Heping has invested approximately 53.2734 million yuan in research and development for this project. Currently, Difluprednate Eye Drops is the first generic drug in the country. The global sales are projected to be USD 33 million and USD 24 million for 2023 and 2024, respectively

### Related Stocks

- [600488.CN](https://longbridge.com/en/quote/600488.CN.md)

## Related News & Research

- [Elon Musk Sees Humans on Mars in 5–7 Years — And He Has $112 Billion Riding on It](https://longbridge.com/en/news/294402920.md)
- [Employees Reveal That Blue Origin Stock Is Worthless Just Weeks After SpaceX IPO Turned Employees Into Millionaires](https://longbridge.com/en/news/294389554.md)
- [China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical](https://longbridge.com/en/news/294273054.md)
- [First China-Made Rapid-Acting Insulin Wins US FDA Approval](https://longbridge.com/en/news/294049451.md)
- [12:40 ETLupin Announces U.S. FDA Approval and Launch of Sugammadex Injection](https://longbridge.com/en/news/294394881.md)